TITLE

Towards healthier infertility

AUTHOR(S)
Judson, Olivia P.
PUB. DATE
September 1993
SOURCE
Nature;9/2/1993, Vol. 365 Issue 6441, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the results of a two-year pilot trial on a contraceptive based on a gonadotropin-releasing hormone agonist. Reduction of the relative risk of breast cancer; Absence of premenstrual syndrome; Addition of oestrogen and progesterone pills to the regimen to avoid bone loss associated with menopause.
ACCESSION #
9312093691

 

Related Articles

  • Combination treatment may control androgenic hirsutism. Young, Constance // Dermatology Times;Mar1995, Vol. 16 Issue 3, p29 

    Reports that the gonadotropin-releasing hormone (Gn-RH) agonist leuprolide acetate given with an oral contraceptive has been found to control hirsutism in women. Description of the disorder; Prevalence; Causes; Other drugs for treatment.

  • GnRH Antagonist Produces Similar Results as GnRH-Agonist.  // Fertility Weekly;12/6/2010, p8 

    The article presents a study which aims to determine the effectiveness of luteinizing hormone releasing hormone (GnRH) antagonist and luteinizing hormone releasing hormone (GnRH) agonist protocol in polycystic ovary syndrome (PCOS) patients pretreated with oral contraceptive pill (OCP)....

  • Drop in reimbursement led to drop in inappropriate ADT use.  // PharmacoEconomics & Outcomes News;1/8/2011, Issue 619, p6 

    The article discusses research on the link between the use of androgen deprivation therapy (ADT) and reimbursement for gonadotropin releasing hormone (GnRH) agonists in the U.S., by V. B. Shahinian and colleagues, published in the "New England Journal of Medicine."

  • AHCPR: LHRH agonists are equally effective.  // Urology Times;Mar99, Vol. 27 Issue 3, p3 

    Cites an Agency for Health Policy Research report which said that luteinizing hormone-releasing agonists produce roughly the same survival and side effects in men with advanced prostate cancer, regardless of which of the testosterone-suppressing drugs is taken.

  • Male contraception. Mathew, Vivek; Bantwal, Ganapathi // Indian Journal of Endocrinology & Metabolism;Nov/Dec2012, Vol. 16 Issue 6, p910 

    Contraception is an accepted route for the control of population explosion in the world. Traditionally hormonal contraceptive methods have focused on women. Male contracept ion by means of hormonal and non hormonal methods is an attractive alternative. Hormonal methods of contraception using...

  • The treatment of advanced prostate cancer with ketoconazole: safety issues. Bok, R.A.; Small, E.J. // Drug Safety;May1999, Vol. 20 Issue 5, p451 

    The definition of hormone refractory prostate cancer is changing. It has become clear that patients with advanced prostate cancer whose disease has progressed following treatment with luteinising hormone releasing hormone agonists and antiandrogens can respond to additional hormonal manoeuvres....

  • Early Results of LH-RH Agonist Treatment with or without Chlormadinone Acetate for Hormone Therapy of Naive Localized or Locally Advanced Prostate Cancer: A Prospective and Randomized Study. Akaza, Hideyuki; Homma, Yukio; Okada, Kiyoki; Yokoyama, Masao; Moriyama, Nobuo; Usami, Michiyuki; Hirao, Yoshihiko; Tsushima, Tomoyasu; Ohashi, Yasuo; Aso, Yoshio // Japanese Journal of Clinical Oncology;Mar2000, Vol. 30 Issue 3, p131 

    Studies the effects of lutenizing hormone-releasing hormone agonist treatment with or without chlormadinone acetate on patients with localized and locally advanced prostate cancer in Japan. Percentage of patients in both treatment groups who showed a complete response (CR); Improvement to CR of...

  • Current and future medical treatment of adenomyosis. Tosti, Claudia; Tro├Ča, Libera; Vannuccini, Silvia; Lazzeri, Lucia; Luisi, Stefano; Petraglia, Felice // Journal of Endometriosis & Pelvic Pain Disorders;Oct-Dec2016, Vol. 8 Issue 4, p127 

    Adenomyosis is a benign gynecological disorder associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia and infertility, requiring a life-long management plan through medical or surgical treatment. The choice depends on woman's age, reproductive status and clinical symptoms. However,...

  • Combination helps reverse overgrowth of hair due to androgen excess.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p33 

    Reports on the effect of a gonadotropin-releasing hormone (GnRH) agonist on severe hair growth according to research findings by Dr. Karen Elkind-Hirsch. Comparison of hypertrichosis treatments given to patients in Elkind-Hirsch's study; Inhibitory effect of GnRH agonists on ovarian steroid...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics